Arteriovenous malformations in mice lacking activin receptor-like kinase-1

被引:0
|
作者
Lisa D. Urness
Lise K. Sorensen
Dean Y. Li
机构
[1] Program in Human Molecular Biology & Genetics,Department of Medicine
[2] University of Utah,Department of Oncological Sciences
[3] University of Utah,undefined
[4] Howard Hughes Medical Institute,undefined
[5] University of Utah,undefined
[6] University of Utah,undefined
来源
Nature Genetics | 2000年 / 26卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The mature circulatory system is comprised of two parallel, yet distinct, vascular networks that carry blood to and from the heart. Studies have suggested that endothelial tubes are specified as arteries and veins at the earliest stages of angiogenesis, before the onset of circulation1,2,3,4. To understand the molecular basis for arterial-venous identity, we have focused our studies on a human vascular dysplasia, hereditary haemorrhagic telangiectasia (HHT), wherein arterial and venous beds fail to remain distinct. Genetic studies have demonstrated that HHT can be caused by loss-of-function mutations in the gene encoding activin receptor-like kinase-1 (ACVRL1; ref. 5). ACVRL1 encodes a type I receptor for the TGF-β superfamily of growth factors6,7,8. At the earliest stage of vascular development, mice lacking Acvrl1 develop large shunts between arteries and veins, downregulate arterial Efnb2 and fail to confine intravascular haematopoiesis to arteries. These mice die by mid-gestation with severe arteriovenous malformations resulting from fusion of major arteries and veins. The early loss of anatomical, molecular and functional distinctions between arteries and veins indicates that Acvrl1 is required for developing distinct arterial and venous vascular beds.
引用
收藏
页码:328 / 331
页数:3
相关论文
共 50 条
  • [21] The orphan ligand, activin C, signals through activin receptor-like kinase 7
    Goebel, Erich J.
    Ongaro, Luisina
    Kappes, Emily C.
    Vestal, Kylie
    Belcheva, Elitza
    Castonguay, Roselyne
    Kumar, Ravindra
    Bernard, Daniel J.
    Thompson, Thomas B.
    Davis, Roger J.
    ELIFE, 2022, 11
  • [22] The Expression of Activin Receptor-Like Kinase 1 among Patients with Head and Neck Cancer
    Chien, Chih-Yen
    Chuang, Hui-Ching
    Chen, Chang-Han
    Fang, Fu-Min
    Chen, Wei-Chih
    Huang, Chao-Cheng
    Huang, Hsuan-Ying
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2013, 148 (06) : 965 - 973
  • [23] Targeting tumour vasculature by inhibiting activin receptor-like kinase (ALK)1 function
    de Vinuesa, Amaya Garcia
    Bocci, Matteo
    Pietras, Kristian
    ten Dijke, Peter
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 1142 - 1149
  • [24] Cloning and partial sequencing of a novel human activin receptor-like kinase
    Ohno, T
    Imai, A
    Takagi, A
    Horibe, S
    Takagi, H
    Tamaya, T
    ONCOLOGY REPORTS, 1997, 4 (06) : 1349 - 1351
  • [25] Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor
    Renlund, Nina
    O'Neill, Francis H.
    Zhang, LiHua
    Sidis, Yisrael
    Teixeira, Jose
    JOURNAL OF ENDOCRINOLOGY, 2007, 195 (01) : 95 - 103
  • [26] Endoglin and Activin Receptor-like Kinase 1 (Alk1) Modify Adrenomedullin Expression in an Organ-Specific Manner in Mice
    Garcia-Sanmartin, Josune
    Narro-Iniguez, Judit
    Rodriguez-Barbero, Alicia
    Martinez, Alfredo
    BIOLOGY-BASEL, 2022, 11 (03):
  • [27] Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
    Johnson, DW
    Berg, JN
    Baldwin, MA
    Gallione, CJ
    Marondel, I
    Yoon, SJ
    Stenzel, TT
    Speer, M
    PericakVance, MA
    Diamond, A
    Guttmacher, AE
    Jackson, CE
    Attisano, L
    Kucherlapati, R
    Porteous, MEM
    Marchuk, DA
    NATURE GENETICS, 1996, 13 (02) : 189 - 195
  • [28] The Role of Activin Receptor-Like Kinase 1 Signaling in the Pulmonary Vasculature of Experimental Diaphragmatic Hernia
    Hofmann, Alejandro Daniel
    Zimmer, Julia
    Takahashi, Toshiaki
    Gosemann, Jan-Hendrik
    Puri, Prem
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2016, 26 (01) : 106 - 111
  • [29] Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
    Cunha, Sara I.
    Pardali, Evangelia
    Thorikay, Midory
    Anderberg, Charlotte
    Hawinkels, Lukas
    Goumans, Marie-Jose
    Seehra, Jasbir
    Heldin, Carl-Henrik
    ten Dijke, Peter
    Pietras, Kristian
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (01): : 85 - 100
  • [30] Two Rare Conditions Linked By An Activin Receptor-Like Kinase 1 (alk-1) Mutation
    McCambridge, A.
    Cartin-Ceba, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193